Trials / Terminated
TerminatedNCT02435303
Effect of Sildenafil for Sustained PAH After MV Surgery (SUPERIOR Trial)
Effect of Sildenafil for the Treatment of Sustained Pulmonary Artery Hypertension After Corrected Mitral Valve Disease
- Status
- Terminated
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 2 (actual)
- Sponsor
- Asan Medical Center · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether Sildenafil is effective in the treatment of sustained pulmonary artery hypertension after corrected mitral valve disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sildenafil | |
| DRUG | Placebo |
Timeline
- Start date
- 2016-05-01
- Primary completion
- 2018-06-01
- Completion
- 2018-06-01
- First posted
- 2015-05-06
- Last updated
- 2019-07-05
Source: ClinicalTrials.gov record NCT02435303. Inclusion in this directory is not an endorsement.